As of 10:25am ET
| -0.0061 / -0.91%|
The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 42.00, with a high estimate of 42.00 and a low estimate of 42.00. The median estimate represents a +6,253.05% increase from the last price of 0.66.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.